Evommune, Inc. (NYSE: EVMN)

Sector: Healthcare Industry: Biotechnology CIK: 0002044725
Market Cap 222.26 Mn
P/B -1.21
P/E -3.25
P/S 31.75
ROIC (Qtr) 0.00
Div Yield % 0.00
Rev 1y % (Qtr) 0.00
Total Debt (Qtr) 160,000.00
Debt/Equity (Qtr) 0.00

About

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 28.23M provide 176.44x coverage of short-term debt 160000, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 84.54M provides 528.40x coverage of total debt 160000, indicating robust asset backing and low credit risk.
  • Short-term investments of 49.24M provide solid 7.37x coverage of other current liabilities 6.68M, indicating strong liquidity.
  • Retained earnings of (192.82M) represent substantial 1.05x of equity (183.14M), indicating strong internal capital generation.
  • Tangible assets of 84.54M provide robust 12.66x coverage of other current liabilities 6.68M, indicating strong asset backing.

Bear case

  • Tangible assets of 84.54M provide limited backing for working capital of 71.53M, which is 1.18x, suggesting increased operational risk in market downturns.

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 SMMT Summit Therapeutics Inc. 1,151.25 Bn -1,249.17 0.00 0.01 Bn
2 ONC BeOne Medicines Ltd. 485.22 Bn 7,078.40 97.58 1.90 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma 122.74 Bn 33.40 10.47 1.83 Bn
4 REGN Regeneron Pharmaceuticals, Inc. 82.16 Bn 18.24 5.73 2.71 Bn
5 ARGX Argenx Se 48.85 Bn 32.43 25,472.44 -
6 ALNY Alnylam Pharmaceuticals, Inc. 46.12 Bn 1,058.58 14.37 3.21 Bn
7 BNTC Benitec Biopharma Inc. 42.24 Bn -1,010.00 0.00 0.00 Bn
8 INSM INSMED Inc 28.75 Bn -24.29 64.32 0.74 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.00 11.11
EV to Cash from Ops. EV to Cash from Ops. 0.00 26.32
EV to Debt EV to Debt 0.00 688.48
EV to EBIT EV to EBIT 0.00 -10.97
EV to EBITDA EV to EBITDA 0.00 8.32
EV to Free Cash Flow [EV/FCF] EV to Free Cash Flow [EV/FCF] 0.00 25.03
EV to Market Cap EV to Market Cap 0.00 163.46
EV to Revenue EV to Revenue 0.00 148.57
Price to Book Value [P/B] P/B -1.21 20.73
Price to Earnings [P/E] P/E -3.25 -0.34
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -12.47
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 0.17
Dividend per Basic Share Div per Share (Qtr) 0.00 0.01
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 -0.14
Interest Coverage Interest Coverage 0.00 860.86
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex Growth (1y) % 0.00 -26.99
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 0.00 756.75
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.01
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 0.00 -53.03
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 0.00 -4.42
EBIT Growth (1y) % EBIT 1y % (Qtr) 0.00 -62.56
EBT Growth (1y) % EBT 1y % (Qtr) 0.00 -19.19
EPS Growth (1y) % EPS 1y % (Qtr) 0.00 -4.07
FCF Growth (1y) % FCF 1y % (Qtr) 0.00 -33.40
Gross Profit Growth (1y) % Gross Profit Growth (1y) % 0.00 264.38
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 0.14
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.00
Cash Ratio Cash Ratio (Qtr) 2.71 3.81
Current Ratio Curr Ratio (Qtr) 7.87 7.25
Debt to Equity Ratio Debt/Equity (Qtr) 0.00 0.43
Interest Cover Ratio Interest Cover Ratio 0.00 860.86
Times Interest Earned Times Interest Earned 0.00 860.86
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 0.00 -17,746.13
EBIT Margin % EBIT Margin % (Qtr) 0.00 -18,101.92
EBT Margin % EBT Margin % (Qtr) 0.00 -18,961.86
Gross Margin % Gross Margin % (Qtr) 0.00 -9.24
Net Profit Margin % Net Margin % (Qtr) 0.00 -18,911.61